Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Amgen reports strong earnings, despite major investor Souders Financial reducing its stake.
Souders Financial Advisors reduced its Amgen stake by 42.9%, now owning 6,163 shares, while Csenge Advisory Group increased its holdings by 204 shares.
Amgen reported a revenue increase of 9.4% to $8.15 billion and earnings of $4.90 per share, exceeding expectations.
The company develops treatments for conditions like psoriasis and arthritis.
Analyst ratings are mixed, with opinions ranging from 'hold' to 'strong buy'.
11 Articles
Amgen reporta fuertes ganancias, a pesar de la reducción de su participación por parte del importante inversor Souders Financial.